WallStreetZenWallStreetZen

NASDAQ: CRSP
Crispr Therapeutics Ag Stock Ownership - Who owns Crispr Therapeutics Ag?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Crispr Therapeutics Ag insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Naimish PatelChief Medical Officer2025-05-293,932$35.94
$141.32kSell
Raju PrasadChief Financial Officer2025-03-212,197$41.23
$90.58kSell
James R. KasingerGeneral Counsel and Secretary2025-03-213,185$41.23
$131.32kSell
Samarth KulkarniChief Executive Officer2025-03-2110,031$41.23
$413.58kSell
Julianne BrunoChief Operating Officer2025-03-211,714$41.23
$70.67kSell
Raju PrasadChief Financial Officer2025-03-173,762$41.80
$157.25kSell
Samarth KulkarniChief Executive Officer2025-03-124,462$43.32
$193.29kSell
Julianne BrunoChief Operating Officer2025-03-12190$43.32
$8.23kSell
James R. KasingerGeneral Counsel and Secretary2025-03-121,116$43.32
$48.35kSell
Julianne BrunoChief Operating Officer2025-03-111,198$42.42
$50.82kSell

1 of 3

CRSP insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CRSP insiders and whales buy or sell their stock.

CRSP Shareholders

What type of owners hold Crispr Therapeutics Ag stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ark Investment Management LLC11.77%10,165,400$420.44MInstitution
Celgene Corp9.91%8,557,514$353.94MInsider
Capital International Investors7.03%6,073,118$251.18MInstitution
Vertex Pharmaceuticals Europe Ltd6.23%5,380,940$222.56MInsider
Bayer Global Investments Bv5.91%5,105,330$211.16MInsider
Simeon George4.94%4,269,578$176.59MInsider
T Rowe Price Investment Management Inc4.40%3,798,103$157.09MInstitution
Glaxosmithkline PLC3.73%3,220,627$133.21MInsider
Blackrock Inc3.03%2,613,539$108.10MInstitution
Nikko Asset Management Americas Inc2.94%2,539,889$105.05MInstitution

1 of 3

CRSP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CRSP65.79%34.21%Net SellingNet Selling
SRPT75.07%24.93%Net SellingNet Buying
RARE84.71%15.29%Net SellingNet Selling
SWTX63.25%36.75%Net Selling
ACAD72.62%27.38%Net SellingNet Selling
View Top Biotech Stocks

Crispr Therapeutics Ag Stock Ownership FAQ

Who owns Crispr Therapeutics Ag?

Crispr Therapeutics Ag (NASDAQ: CRSP) is owned by 74.27% institutional shareholders, 38.61% Crispr Therapeutics Ag insiders, and 0.00% retail investors. Celgene Corp is the largest individual Crispr Therapeutics Ag shareholder, owning 8.56M shares representing 9.91% of the company. Celgene Corp's Crispr Therapeutics Ag shares are currently valued at $353.94M.

If you're new to stock investing, here's how to buy Crispr Therapeutics Ag stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.